It has been demonstrated that PRL can stimulate human hematopoietic CD34 + progenitor cells [4] and that treatment with drug inducing PRL release (e.g. metoclopramide) improved the hematocrit in subgroups of patients with anemia [5]. Here, PRL is linked to anemia.